MedTrace Logo

PET-CT Scans in Healthy Volunteers After Flu Vaccination

NCT00769002 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 18

Last updated 2020-10-19

Study results available
· View outcomes & findings →

Summary

This study is being done to learn how previous flu vaccination or previous infection with flu virus affects the immune response to vaccination.

Conditions

Interventions

BIOLOGICAL

FluShield

Flu vaccine

BIOLOGICAL

FluShield - same arm

Flu vaccine

BIOLOGICAL

FluShield - opposite arm

Flu vaccine

PROCEDURE

Blood Draws

50 cc of heparinized blood and 10 cc of serum at study entry and at 10-12 week post vaccination

PROCEDURE

FDG PET-CT Scan

PET scan

GENETIC

Cytokine Profiling

Blood draw for Cytokine Profiling Draw at 2,4 and 6 weeks post vaccination

Sponsors & Collaborators

  • National Institutes of Health (NIH)

    collaborator NIH

  • National Institute of Allergy and Infectious Diseases (NIAID)

    collaborator NIH

  • Hackensack Meridian Health

    lead OTHER

Principal Investigators

  • David Schwartz, MD, PhD · Hackensack Meridian Health

Study Design

Allocation
NON_RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
21 Years
Max Age
55 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2008-09-30
Primary Completion
2011-08-31
Completion
2011-08-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00769002 on ClinicalTrials.gov